Neuro-Oncology: The Podcast

Duración total:14 h 37 min
Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma
Neuro-Oncology: The Podcast
02:29
SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology
Neuro-Oncology: The Podcast
23:04
Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors
Neuro-Oncology: The Podcast
20:41
Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG
Neuro-Oncology: The Podcast
02:52
Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology
Neuro-Oncology: The Podcast
42:50
Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma
Neuro-Oncology: The Podcast
17:33
Hot Topics: Clinician-Patient Relationship in Neuro-Oncology
Neuro-Oncology: The Podcast
28:49
Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma
Neuro-Oncology: The Podcast
03:30
SNObound: Career Advice from Dr. Gelareh Zadeh
Neuro-Oncology: The Podcast
31:06
Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma
Neuro-Oncology: The Podcast
20:47
Hot Topics: Radiation Hypofractionation in Glioma
Neuro-Oncology: The Podcast
17:36
Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma
Neuro-Oncology: The Podcast
02:52
Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association
Neuro-Oncology: The Podcast
19:32
Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma
Neuro-Oncology: The Podcast
17:18
Hot Topics: How longitudinal profiling of glioma informs therapy development
Neuro-Oncology: The Podcast
19:20
Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma
Neuro-Oncology: The Podcast
03:00
SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis
Neuro-Oncology: The Podcast
34:24
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
Neuro-Oncology: The Podcast
23:18
Introduction to Neuro-Oncology: The Podcast 2.0
Neuro-Oncology: The Podcast
07:57
Radiotherapy induced neurocognitive decline
Neuro-Oncology: The Podcast
16:05
QOL and cognitive functioning in patients with oligodendroglioma
Neuro-Oncology: The Podcast
18:22
Post-operative radiation in recurrent grade 1 meningiomas
Neuro-Oncology: The Podcast
19:39
mRNA CAR T against GD2 in high-grade glioma models
Neuro-Oncology: The Podcast
29:43
A transcriptomic atlas of CNS tumors
Neuro-Oncology: The Podcast
35:22
Gut microbiome in primary CNS lymphoma
Neuro-Oncology: The Podcast
15:04
Germline analysis of diffuse midline glioma
Neuro-Oncology: The Podcast
29:55
The proteomic landscape of diffuse midline glioma
Neuro-Oncology: The Podcast
16:55
Radio-Pathomic maps and MR perfusion
Neuro-Oncology: The Podcast
20:25
CSF proteomics in glioma
Neuro-Oncology: The Podcast
44:15
Vorasidenib in IDH mutant glioma
Neuro-Oncology: The Podcast
42:44
KL-50 in post TMZ MMR-deficient GBM
Neuro-Oncology: The Podcast
21:33
Measurable disease per FET-PET vs MRI in GBM
Neuro-Oncology: The Podcast
14:06
Pre-radiation chemotherapy in GBM
Neuro-Oncology: The Podcast
13:42
cIMPACT-NOW Update 8: grading of meningiomas
Neuro-Oncology: The Podcast
43:16
Residual tumor volume and survival after CCNU/TMZ in GBM
Neuro-Oncology: The Podcast
13:18
Alterations in RNA splicing between meningioma DNA methylation groups
Neuro-Oncology: The Podcast
33:46
The immune landscape of IDH mutant and IDHwt glioma
Neuro-Oncology: The Podcast
33:27
Equity-driven applications of AI in neuro-oncology
Neuro-Oncology: The Podcast
22:34
IDH mutant glioma across age groups
Neuro-Oncology: The Podcast
34:34
Contemporary molecular prognostic signatures in glioma
Neuro-Oncology: The Podcast
20:00